These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 18062685

  • 1. Synthesis, characterization, and in vitro evaluation of a potentially selective anticancer, mixed-metal [ruthenium(III)-platinum(II)] trinuclear complex.
    Herman A, Tanski JM, Tibbetts MF, Anderson CM.
    Inorg Chem; 2008 Jan 07; 47(1):274-80. PubMed ID: 18062685
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).
    Velders AH, Bergamo A, Alessio E, Zangrando E, Haasnoot JG, Casarsa C, Cocchietto M, Zorzet S, Sava G.
    J Med Chem; 2004 Feb 26; 47(5):1110-21. PubMed ID: 14971891
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis, structural characterization, solution chemistry, and preliminary biological studies of the ruthenium(III) complexes [TzH][trans-RuCl4(Tz)2] and [TzH][trans-RuCl4(DMSO)(Tz)].(DMSO), the thiazole analogues of antitumor ICR and NAMI-A.
    Mura P, Camalli M, Messori L, Piccioli F, Zanello P, Corsini M.
    Inorg Chem; 2004 Jun 28; 43(13):3863-70. PubMed ID: 15206867
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dinuclear ruthenium(II) triple-stranded helicates: luminescent supramolecular cylinders that bind and coil DNA and exhibit activity against cancer cell lines.
    Pascu GI, Hotze AC, Sanchez-Cano C, Kariuki BM, Hannon MJ.
    Angew Chem Int Ed Engl; 2007 Jun 28; 46(23):4374-8. PubMed ID: 17477461
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis and reactivity of the aquation product of the antitumor complex trans-[Ru(III)Cl4(indazole)2]-.
    Cebrián-Losantos B, Reisner E, Kowol CR, Roller A, Shova S, Arion VB, Keppler BK.
    Inorg Chem; 2008 Jul 21; 47(14):6513-23. PubMed ID: 18553904
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis, molecular structure and evaluation of new organometallic ruthenium anticancer agents.
    Camm KD, El-Sokkary A, Gott AL, Stockley PG, Belyaeva T, McGowan PC.
    Dalton Trans; 2009 Dec 28; (48):10914-25. PubMed ID: 20023922
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: synthesis, characterisation and preliminary evaluation of biological activity.
    Ji L, Zheng W, Lin Y, Wang X, Lü S, Hao X, Luo Q, Li X, Yang L, Wang F.
    Eur J Med Chem; 2014 Apr 22; 77():110-20. PubMed ID: 24631730
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthetic route to dinuclear platinum(II) complexes [{trans-PtCl(NH3)2}2(mu-L)]2+ (L = aliphatic or heterocyclic diamine) as potential antitumor agents, exploiting the mutual activation of hydroxido ligands and ammonium groups.
    Chopard C, Lenoir C, Rizzato S, Vidal M, Arpalahti J, Gabison L, Albinati A, Garbay C, Kozelka J.
    Inorg Chem; 2008 Oct 20; 47(20):9701-5. PubMed ID: 18817377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.